Latest filing published 12 Dec 2016 for Aralez Pharmaceuticals Inc..
Insider track record
Seth Rudnick: trading record in brief
Seth Rudnick discloses dealings in Aralez Pharmaceuticals Inc. to SEC (Form 4). Over a trading history stretching from 5 February 2016 to 23 November 2016, the count stands at 8 filings.
Every open-market trade on record is a purchase: 5 purchases worth €98k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 option exercise.
A typical purchase (the median) is worth €22k. Across 5 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The record was last updated on 12 December 2016 with a transaction in Aralez Pharmaceuticals Inc. The latest purchase dates back some time: it was published 3,647 days ago, on 15 November 2016. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Seth Rudnick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 30,000 sharesCommon SharesTSXSEDI:2925873
- 10,000 shares@ CA$4.829927.2% of flowCommon SharesTSXSEDI:2912958Canonical exit: 9 Feb 2017 (T+90)
- 1,681 shares@ CA$4.784.5% of flowCommon SharesTSXSEDI:2912960Canonical exit: 9 Feb 2017 (T+90)
- 6,819 shares@ CA$4.8018.5% of flowCommon SharesTSXSEDI:2912961Canonical exit: 9 Feb 2017 (T+90)
- 10,000 shares@ CA$4.6926.4% of flowCommon SharesTSXSEDI:2912957Canonical exit: 9 Feb 2017 (T+90)
- 1,500 shares@ CA$4.774.0% of flowCommon SharesTSXSEDI:2912959Canonical exit: 9 Feb 2017 (T+90)
- 9,390 shares@ CA$3.5819.3% of flowCommon SharesTSXSEDI:2851567
- Common SharesTSXSEDI:2787427
8 of 8 declarations
